Catalyst Pharmaceuticals (CPRX) Other Gross PP&E Adjustments: 2012-2025
Historic Other Gross PP&E Adjustments for Catalyst Pharmaceuticals (CPRX) over the last 14 years, with Sep 2025 value amounting to -$10.9 million.
- Catalyst Pharmaceuticals' Other Gross PP&E Adjustments fell 2.04% to -$10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$71.9 million, marking a year-over-year decrease of 87.14%. This contributed to the annual value of -$12.2 million for FY2024, which is 95.15% down from last year.
- Catalyst Pharmaceuticals' Other Gross PP&E Adjustments amounted to -$10.9 million in Q3 2025, which was up 44.80% from -$19.7 million recorded in Q2 2025.
- Catalyst Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at -$1.4 million for Q1 2024, and its period low was -$29.1 million during Q1 2025.
- Over the past 3 years, Catalyst Pharmaceuticals' median Other Gross PP&E Adjustments value was -$10.7 million (recorded in 2024), while the average stood at -$10.5 million.
- Per our database at Business Quant, Catalyst Pharmaceuticals' Other Gross PP&E Adjustments tumbled by 17,603.62% in 2021 and then grew by 16.58% in 2022.
- Quarterly analysis of 5 years shows Catalyst Pharmaceuticals' Other Gross PP&E Adjustments stood at -$2.0 million in 2021, then grew by 12.13% to -$1.8 million in 2022, then crashed by 248.99% to -$6.2 million in 2023, then crashed by 95.15% to -$12.2 million in 2024, then fell by 2.04% to -$10.9 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$10.9 million for Q3 2025, versus -$19.7 million for Q2 2025 and -$29.1 million for Q1 2025.